Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LSS | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
mRNA | SLC22A13 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
mRNA | ST8SIA4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
mRNA | FAM193A | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
mRNA | CNTNAP5 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
mRNA | GAGE1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
mRNA | IP6K3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
mRNA | ZBTB22 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | SCLT1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
mRNA | AVPR1B | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |